Emerging targets in sarcoma: Rising to the challenge of RAS signaling in undifferentiated pleomorphic sarcoma

By Dodd Rebecca D.  

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 17-19

Blackwell Publishing

Access to resources Recommend Favorite

Multitarget Network Strategies to Influence Memory and Forgetting: The Ras/Mapk Pathway as a Novel Option

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 8, 2015-06 ,pp. : 696-704

Bentham Science Publishers

Access to resources Recommend Favorite

Initial Design and Synthesis of Conformationally Restricted and Pharmacophore-Based Scaffold Hopping Analogs of a Ras Pathway Modulator and Evaluation of Their MAPK Inhibitory Activities

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 1, 2006-02 ,pp. : 44-48

Bentham Science Publishers

Access to resources Recommend Favorite

Agents Targeting Ras Signaling Pathway

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2259-2267

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Spectrum of Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma in Solid Organ Transplant Recipients: A Collective Experience

By McCoppin Holly H.   Christiansen Daniel   Stasko Thomas   Washington Carl   Martinez Juan Carlos   Brown Marc D.   Zwald Fiona O.  

Dermatologic Surgery, Vol. 38, Iss. 2, 2012-02 ,pp. : 230-239

Elsevier

Access to resources Recommend Favorite